Anacor’s crisaborole achieves primary and secondary endpoints in two Phase 3 studies in eczema
13 July 2015 | By Victoria White
Anacor has announced positive preliminary top-line results from its two Phase 3 pivotal studies of crisaborole in atopic dermatitis (eczema)...